NCT07031323Completed
OnTrackCF: Engagement, Feasibility, and Acceptability Study
Source: ClinicalTrials.gov · Last updated 27 Oct 2026
Brief summary (registry, in English)
This is a multi-site, nonrandomized study using mixed methods approach to evaluate the feasibility, acceptability, and user engagement of OnTrackCF for adults with Cystic Fibrosis (AWCF).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 25 (actual)
- First submitted
- 9 Jun 2025
- Start date
- 20 Nov 2025
- Primary completion date
- 18 Sept 2026
- Lead sponsor
- Boston Children's Hospital
- Diseases
- Cystic fibrosis
- NCT number
- NCT07031323
What you commit to
- Study type: Interventional
- Participants enrolled: 25
- From 20 Nov 2025 to the primary completion date, 18 Sept 2026
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- 1\) Any situation, in the opinion of the Investigator, that would compromise the safety of the patient or the quality of the data
Who the study is looking for
- Diagnosed with CF
- 18+ years of age
- Prescribed a CFTR modulator therapy to be taken twice a day
- Can speak and read English
- Have regular access to an iOS or Android tablet or smartphone with internet access.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Johns Hopkins University Coordinator of this site? Confirm its status | Baltimore | United States | Unknown status |
| University of Alabama Birmingham Coordinator of this site? Confirm its status | Birmingham | United States | Unknown status |
| Boston Children's Hospital Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.